Polarean Imaging (LON:POLX) pulls back 12% this week, but still delivers shareholders respectable 9.7% CAGR over 5 years - Simply Wall St News
![Hargreaves Lansdown investors are buying Polarean Imaging shares. Should I buy too? | The Motley Fool UK Hargreaves Lansdown investors are buying Polarean Imaging shares. Should I buy too? | The Motley Fool UK](https://www.fool.co.uk/wp-content/uploads/gravatar/edward-sheldoncfa-3.jpg)
Hargreaves Lansdown investors are buying Polarean Imaging shares. Should I buy too? | The Motley Fool UK
![Polarean Imaging (POLX) Share Price Rallied 5.51% as It Recovered From the FDA Crash | AskTraders.com Polarean Imaging (POLX) Share Price Rallied 5.51% as It Recovered From the FDA Crash | AskTraders.com](https://www.asktraders.com/wp-content/uploads/2021/10/Polarean-imaging-share-price-13-10-2021.jpg)
Polarean Imaging (POLX) Share Price Rallied 5.51% as It Recovered From the FDA Crash | AskTraders.com
Polarean Imaging's (LON:POLX) investors will be pleased with their notable 96% return over the last three years
Earnings Flash (POLX.L) POLAREAN IMAGING Posts H1 Loss $-0.04 -Yesterday at 02:04 am| MarketScreener
polarean Share Chat. Chat About POLX Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.
![Polarean Imaging Stock Forecast: down to 0.000001 GBX? - POLX Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Polarean Imaging Stock Forecast: down to 0.000001 GBX? - POLX Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/62/stock-polx-stock-forecast.png?v=1702326115)
Polarean Imaging Stock Forecast: down to 0.000001 GBX? - POLX Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
![Justin Waite on X: ""Upon FDA approval (90% probability), we value Polarean #POLX at 135p per share on a risk-adjusted NPV basis, which implies c.50% upside to the current share price, hence Justin Waite on X: ""Upon FDA approval (90% probability), we value Polarean #POLX at 135p per share on a risk-adjusted NPV basis, which implies c.50% upside to the current share price, hence](https://pbs.twimg.com/media/E0xXyKuWUAEtZsl.png)